daratumumab, bortezomib & dexamethasone at first relapse: real-world study in patients with myeloma
Published 1 year ago • 857 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:22
daratumumab and dexamethasone in the treatment of patients with myeloma and severe renal impairment
-
1:54
castor trial update: daratumumab/bortezomib/dexamethasone is an important regimen for r/r mm
-
1:29
bendamustine-bortezomib-dexamethasone in r/r multiple myeloma
-
14:28
all about darzalex (daratumumab)
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
15:09
subcutaneous daratumumab — dr. jonathan kaufman | mcrt webcast july 11
-
9:48
darzalex ( daratumumab injection )- generic ,brand names , precautions , to use, side effects
-
12:57
darzalex faspro® (daratumumab and hyaluronidase-fihj) mechanism of action for multiple myeloma
-
2:16
mechanism of action & use of daratumumab in multiple myeloma
-
2:13
daratumumab in the treatment of multiple myeloma
-
4:01
choosing between isatuximab & daratumumab in multiple myeloma
-
2:36
efficacy and safety of daratumumab, bortezomib, and dex (d-vd) vs vd in first relapse patients
-
2:49
daratumumab in myeloma update: expanding indications
-
3:51
daratumumab in multiple myeloma: an overview of 3 key trials
-
0:52
the future of daratumumab in multiple myeloma
-
2:04
a novel mechanism of action for daratumumab in myeloma
-
1:52
analyzing isatuximab in quadruplet combinations in transplant-ineligible multiple myeloma
-
2:41
preliminary data on mezigdomide plus dexamethasone and bortezomib in r/r multiple myeloma
-
1:36
relevance of panobinostat-bortezomib-dexamethasone in r/r myeloma in the era of novel agents
-
1:51
darazadex: a phase ii trial of daratumumab plus azacitidine and dexamethasone in r/r myeloma
-
3:27
case study: daratumumab in a relapsed patient
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines